Propofol Injection IP In Stock
Pharmaceuticals Injections

Propofol Injection IP

Propofol Injection IP is a short-acting intravenous anesthetic used to induce and maintain general anesthesia and provide sedation during selected medical procedures under specialist supervision.

Product Details

Propofol Injection IP contains propofol, a short-acting intravenous anesthetic medicine. It is used to induce and maintain general anesthesia during surgery and to provide sedation for certain diagnostic or medical procedures. It may also be used for sedation in patients receiving mechanical ventilation in intensive care settings, when clinically appropriate.

Key Benefits
- Provides rapid induction of general anesthesia
- Helps maintain anesthesia during surgical procedures
- Provides sedation during selected diagnostic and medical procedures
- Supports controlled sedation in appropriate intensive care settings
- Has a rapid onset and relatively short duration of action
How It Works
Propofol enhances the activity of gamma-aminobutyric acid (GABA) in the central nervous system, producing sedation, hypnosis, and loss of consciousness. Its rapid onset and short duration make it suitable for controlled intravenous anesthesia and sedation.
Common Side Effects
- Low blood pressure
- Slow heart rate
- Pain or discomfort at the injection site
- Temporary breathing suppression
- Nausea and vomiting
- Headache
- Dizziness
- Temporary involuntary movements
Important Information
Propofol Injection IP must be administered intravenously by trained anesthesia or critical-care professionals in a properly equipped clinical setting. Continuous monitoring of breathing, oxygen levels, blood pressure, and heart function is essential because propofol can cause significant respiratory and cardiovascular depression. Appropriate airway and resuscitation equipment should be immediately available. The dose and rate of administration must be individualized according to the patient's condition and the intended level of anesthesia or sedation.